IBBvsSPMD
iShares Biotechnology ETF against SPDR Portfolio S&P 400 Mid Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBB | SPMD | |
|---|---|---|
| Expense ratio | 0.45% | 0.030% |
| Assets | $10.7B | $17.9B |
| Net flow, 1 month | +$656M | +$207M |
| Net flow, 1 year | +$2.2B | +$2.1B |
| Return, YTD | +22.0% | +10.0% |
| Return, 1 year | +38.7% | +11.0% |
| Avg daily volume | 1.5M | 1.5M |
| Holdings | 221 | 401 |
| Listed | Feb 5, 2001 | Nov 8, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS